Cited by 5Probiotics and Fermented FoodsGut microbiota and healthReproductive tract infections research

Evaluation of the Decreased Cholesterol Potential of Levilactobacillus brevis M-10 Isolated from Spontaneously Fermented Sour Porridge in Mice with High-Cholesterol Levels

Wang, Qi, Peng, Jiawei, Tian, Ye, Li, Jianhua, Cai, Jin, Qin, Wenjun·2025·Current Microbiology

Abstract

Excessive cholesterol levels can lead to hypercholesterolemia, which is related to cardiovascular diseases (CVDs), and CVDs are a serious threat to human health. Therefore, lowering cholesterol levels is necessary, and diet intervention is safer than drugs are. The cholesterol-lowering effect of Levilactobacillus brevis M-10 isolated from spontaneously fermented millet sour porridge was investigated in fifty C57BL/6N male mice. After a 4-week intervention, the food intake, weight gains and organ indices were calculated; the lipid contents in the serum, liver, and feces were determined; the histopathology of the liver tissues was observed; the expression of metabolism-related genes was determined; and short-chain fatty acid (SCFA) levels in the droppings were monitored. The results showed that administration of a high dose of L. brevis M-10 (1 × 10 10 CFU/mL) significantly reduced food intake, suppressed weight gain; prevented excessive liver growth; and reduced the total serum cholesterol, triglycerides, low-density lipoproteins; and total hepatic cholesterol and triglyceride contents (P < 0.05) in high-cholesterol mice. Moreover, a high dose of L. brevis M-10 significantly promoted the fecal excretion of cholesterol and triglycerides (P < 0.05) and alleviated liver damage induced by a high-cholesterol diet. Furthermore, a high dose of L. brevis M-10 significantly downregulated the cholesterol metabolism-related gene expression of NPC1L1, ACAT2, HMG-CoA, and SREBP2 but upregulated the gene expression of ABCG5, CYP7A1, and LXR-α (P < 0.05). Additionally, a high dose of L. brevis M-10 significantly increased SCFA contents, including those of acetic acid, propionic acid and n-butyric acid (P < 0.05). These findings could provide support for the use of L. brevis M-10 in the application of functional foods to alleviate hypercholesterolemia.

Integrity signals

Registry

Crossref · 10.1007/s00284-024-03974-5

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, Q., Peng, J., Tian, Y., Li, J., Cai, J., & Qin, W.
Affiliations
  • Shanxi University (CN)
  • Shanxi Provincial People’s Hospital (CN)
  • China Institute for Radiation Protection (CN)
Corresponding author
Qin, Wenjun
Venue
Current Microbiology
Published
2024-11-30
Volume
82
Issue
1
Pages
24-24
ISSN
  • 0343-8651 (ISSN-L)
  • 1432-0991
OpenAlex
W4404862095
Cited by
5
References
39
Citations by year
2026: 2 · 2025: 3
FWCI
1.07
Type
journal article
Language
en
Open access
closed
Locations
  • Current Microbiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Natural Science Foundation of Shanxi Province (20210302123464)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Keywords
Lactobacillus brevis, hypercholesterolemia, cholesterol-lowering effect, probiotics, high-cholesterol diet, hepatic cholesterol metabolism, short-chain fatty acids, fecal cholesterol excretion, liver histopathology, NPC1L1, SREBP2, ABCG5, CYP7A1, liver X receptor alpha, ACAT2, functional foods, cardiovascular disease prevention
MeSH terms
Fermented Foods, Animals, Anticholesteremic Agents, Cholesterol, Fatty Acids, Volatile, Feces, Fermentation, Hypercholesterolemia, Liver, Male, Mice, Inbred C57BL, Triglycerides, Probiotics, Mice, Levilactobacillus brevis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review